methamphetamine has been researched along with Cognitive Decline in 40 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 19 (47.50) | 24.3611 |
| 2020's | 21 (52.50) | 2.80 |
| Authors | Studies |
|---|---|
| Ciccarone, D; Shoptaw, S | 1 |
| Chen, J; Du, Y; Fan, F; Fu, F; Li, Y; Tang, S; Tian, Y; Wang, D; Wang, L; Wei, D; Yang, Y; Zhang, X; Zhu, R | 1 |
| Fan, R; Li, X; Liu, Y; Luo, H; Shen, Y; Si, Z; Zhang, P; Zhou, W | 1 |
| Chen, J; Du, Y; Fan, F; Fu, F; Li, Y; Tang, S; Tian, Y; Wang, DM; Wang, L; Wei, D; Zhang, XY; Zhu, R | 1 |
| Chen, J; Fan, F; Fu, F; Jiang, W; Li, Y; Shi, Z; Tang, S; Tian, Y; Wang, D; Wang, L; Wei, D; Zhang, XY; Zhu, R | 1 |
| Chawang, O; Chetsawang, B; Kraiwattanapirom, N; Lomwong, N; Siripornpanich, V; Suwannapu, W; Unaharassamee, W; Vittayatavornwong, L | 1 |
| Hámor, PU; Knackstedt, LA; Schwendt, M | 1 |
| Dong, G; Kaibuchi, K; Liao, J; Liu, Y; Mizoguchi, H; Nabeshima, T; Nagai, T; Ozaki, N; Sawahata, M; Wulaer, B; Yamada, K; Zhu, W | 1 |
| Al-Mayah, QS; Hashim, ZH; Hussein, MM; Mohammed, SM | 1 |
| Chai, JR; Cheng, YJ; Deng, D; Deng, YZ; Liu, JG; Wang, YJ; Wu, MQ; Zhao, M | 1 |
| Chetsawang, B; Cornish, JL; Na Nakorn, P; Ngampramuan, S; Panmanee, J; Pannengpetch, S; Polvat, T; Prasertporn, T; Suwanjang, W | 1 |
| Chen, H; Cheng, X; Chi, Z; Chu, H; Ge, C; Hu, J; Jiao, D; Li, X; Li, Y; Lin, Y; Ma, M; Shi, W; Song, H; Wu, Y; Xie, Y; Xu, H; Xu, M; Zhai, C; Zhang, Y; Zhao, T | 1 |
| Fitzpatrick, RE; Lubman, DI; Rubenis, AJ; Verdejo-Garcia, A | 2 |
| Ellis, RJ; Grant, I; Heaton, RK; Letendre, S; Morgan, EE; Saloner, R; Serrano, V; Sun-Suslow, N; Umlauf, A | 1 |
| Indrakamhaeng, D; Jantamo, P; Khuwuthyakorn, P; Lamyai, W; Pono, K; Saengsin, A; Songhong, N; Srisurapanont, M | 1 |
| Cortes, LR; Dwyer, MR; Gulley, JM; Westbrook, SR | 1 |
| Chancharoen, P; Govitrapong, P; Lwin, T; Mukda, S; Ngampramuan, S; Pinyomahakul, J; Veschsanit, N; Viwatpinyo, K; Yang, JL | 1 |
| Albertolle, M; Deal, A; Doulias, PT; Ischiropoulos, H; Lipton, SA; McKercher, SR; Nakamura, T; Scott, H; Sultan, A | 1 |
| Bu, L; Dong, G; Qi, L; Tang, L; Tang, Z; Yin, Y | 1 |
| Govitrapong, P; Namyen, J; Nopparat, C; Panmak, P; Permpoonpattana, K | 1 |
| Bao, YP; Fan, TT; Lappin, JM; Li, XD; Lu, L; Shi, J; Wang, TY; Wu, P; Zhao, YM | 1 |
| Callan, SP; Moszczynska, A | 1 |
| Couraud, PO; Hauser, KF; Jahr, FM; Leibrand, CR; McClay, JL; McRae, M; Palasuberniam, P; Patel, S; Weksler, B | 1 |
| Donald, KA; Ipser, J; Kwiatkowski, MA; Roos, A; Stein, DJ; Thomas, KGF | 1 |
| Barr, AM; Grot, S; Hébert, C; Lecomte, T; Pelletier, J; Potvin, S | 1 |
| Du, J; Hashimoto, K; Jiang, H; Yu, S; Zhang, K; Zhang, Q; Zhao, M; Zhou, C | 1 |
| Chen, T; Dong, N; Goh, ELK; Han, W; Ma, D; Wang, S; Yan, Z; Zhu, J | 1 |
| Mizoguchi, H; Yamada, K | 1 |
| Cui, J; Ji, Y; Lai, J; Su, R; Wang, Y; Wei, S; Xu, D; Yan, P; Yin, F; Zhu, Y | 1 |
| Karami, L; Kermanshahi, S; Keshavarzi, S; Motaghinejad, M; Motevalian, M; Sadr, S | 1 |
| Cheng, M; Hao, Y; Jiao, S; Jing, P; Liu, Q; Ma, L; Pan, C; Wang, Y; Wu, Y | 1 |
| Barski, J; Lewin-Kowalik, J; Liśkiewicz, A; Liśkiewicz, D; Małecki, A; Nowacka-Chmielewska, M; Park, M; Przybyła, M; Toborek, M | 1 |
| Basterfield, C; Bowden, SC; Hester, R | 1 |
| Cherner, M; Grant, I; Heaton, RK; Moore, DJ; Paolillo, EW; Saloner, R; Umlauf, A | 1 |
| Lappin, JM; Sara, GE | 1 |
| Du, J; Hashimoto, K; Jiang, H; Li, C; Li, X; Sun, H; Xu, D; Zhao, M; Zhao, Y; Zhong, N; Zhuang, W | 1 |
| Fitzgerald, PB; Hassani-Abharian, P; Molavi, N; Shariatirad, S; Sharifi Fardshad, M; Vaziri, A | 1 |
| Hwang, J; Jeon, S; Kang, I; Kim, B; Kim, GH; Kim, JE; Kim, JY; Lyoo, IK; Ma, J; Renshaw, PF; Yoon, S; Yurgelun-Todd, DA | 1 |
| Bao, YP; Fan, TT; Han, Y; Li, XD; Liang, CM; Lu, L; Ma, J; Meng, SQ; Shi, J; Wang, RJ; Wang, TY; Wu, P | 1 |
7 review(s) available for methamphetamine and Cognitive Decline
| Article | Year |
|---|---|
Understanding Stimulant Use and Use Disorders in a New Era.
Topics: Adrenergic alpha-2 Receptor Antagonists; Adult; Anticonvulsants; Behavior Therapy; Bupropion; Central Nervous System Stimulants; Cocaine-Related Disorders; Cognitive Dysfunction; Comorbidity; Dopamine Uptake Inhibitors; Female; Humans; Illicit Drugs; Male; Mental Disorders; Methamphetamine; Mirtazapine; Neurobiology; Neurodegenerative Diseases; Opiate Overdose; Substance Withdrawal Syndrome; Topiramate; Transgender Persons; United States | 2022 |
The role of metabotropic glutamate receptors in neurobehavioral effects associated with methamphetamine use.
Topics: Central Nervous System; Cognition Disorders; Cognitive Dysfunction; Glutamates; Humans; Methamphetamine | 2023 |
Molecular, Behavioral, and Physiological Consequences of Methamphetamine Neurotoxicity: Implications for Treatment.
Topics: Amphetamine-Related Disorders; Animals; Cognitive Dysfunction; Dopaminergic Neurons; Dose-Response Relationship, Drug; Humans; Methamphetamine; Neural Pathways; Neurotoxicity Syndromes; Serotonergic Neurons | 2017 |
Cognitive deficits in individuals with methamphetamine use disorder: A meta-analysis.
Topics: Amphetamine-Related Disorders; Attention; Cognitive Dysfunction; Executive Function; Humans; Impulsive Behavior; Memory, Short-Term; Methamphetamine; Reward; Social Perception; Spatial Processing | 2018 |
Methamphetamine use causes cognitive impairment and altered decision-making.
Topics: Animals; Central Nervous System Stimulants; Cognitive Dysfunction; Decision Making; Dopamine Agents; Humans; Methamphetamine | 2019 |
A meta-analysis of the relationship between abstinence and neuropsychological functioning in methamphetamine use disorder.
Topics: Adult; Amphetamine-Related Disorders; Central Nervous System Stimulants; Cognitive Dysfunction; Female; Humans; Male; Methamphetamine; Neuropsychological Tests | 2019 |
Psychostimulant use and the brain.
Topics: Amphetamine; Amphetamine-Related Disorders; Brain; Central Nervous System Stimulants; Cocaine; Cocaine-Related Disorders; Cognitive Dysfunction; Humans; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Parkinson Disease, Secondary; Psychoses, Substance-Induced; Seizures; Stroke | 2019 |
2 trial(s) available for methamphetamine and Cognitive Decline
| Article | Year |
|---|---|
Acute VR competitive cycling exercise enhanced cortical activations and brain functional network efficiency in MA-dependent individuals.
Topics: Bicycling; Cognition; Cognitive Dysfunction; Dorsolateral Prefrontal Cortex; Executive Function; Exergaming; Female; Humans; Male; Methamphetamine; Nerve Net; Stroop Test; Substance-Related Disorders; Treatment Outcome; Virtual Reality; Young Adult | 2021 |
Impact of aerobic exercise on cognitive impairment and oxidative stress markers in methamphetamine-dependent patients.
Topics: Adult; Amphetamine-Related Disorders; Antioxidants; Biomarkers; Cognition; Cognitive Dysfunction; Exercise; Exercise Therapy; Female; Humans; Lipid Peroxidation; Male; Methamphetamine; Middle Aged; Oxidative Stress; Treatment Outcome; Verbal Learning | 2018 |
31 other study(ies) available for methamphetamine and Cognitive Decline
| Article | Year |
|---|---|
Differences in cognitive deficits in patients with methamphetamine and heroin use disorder compared with healthy controls in a Chinese Han population.
Topics: Case-Control Studies; China; Cognition; Cognitive Dysfunction; Heroin; Humans; Language; Methamphetamine; Neuropsychological Tests | 2022 |
The effect of the NLRP1 inflammasome on methamphetamine-induced cognitive impairment in rats.
Topics: Animals; Caspases; Cognitive Dysfunction; Inflammasomes; Methamphetamine; Rats; RNA, Small Interfering; Tumor Necrosis Factor-alpha | 2022 |
Prevalence, demographics, and cognitive dysfunction among methamphetamine-dependent individuals with childhood maltreatment.
Topics: Child; Child Abuse; Cognitive Dysfunction; Cross-Sectional Studies; Humans; Male; Methamphetamine; Prevalence; Surveys and Questionnaires | 2022 |
Effects of comorbid posttraumatic stress disorder on cognitive dysfunction in Chinese male methamphetamine patients.
Topics: China; Cognitive Dysfunction; Humans; Language; Male; Methamphetamine; Neuropsychological Tests; Stress Disorders, Post-Traumatic | 2022 |
The quantitative analysis of EEG during resting and cognitive states related to neurological dysfunctions and cognitive impairments in methamphetamine abusers.
Topics: Amphetamine-Related Disorders; Cognition; Cognitive Dysfunction; Electroencephalography; Humans; Methamphetamine | 2022 |
Rho kinase inhibitors ameliorate cognitive impairment in a male mouse model of methamphetamine-induced schizophrenia.
Topics: Animals; Clozapine; Cognitive Dysfunction; Haloperidol; Male; Methamphetamine; Mice; Monomeric GTP-Binding Proteins; Protein Kinase Inhibitors; rho-Associated Kinases; Schizophrenia | 2023 |
Serum brain-derived neurotrophic factor levels in patients with schizophrenia and methamphetamine addiction: correlation with Mini-Mental State Examination (MMSE).
Topics: Amphetamine-Related Disorders; Brain-Derived Neurotrophic Factor; Case-Control Studies; Cognitive Dysfunction; Humans; Methamphetamine; Schizophrenia | 2023 |
Prelimbic cortex dynorphin/κ opioid receptor system modulates methamphetamine-induced cognitive impairment.
Topics: Animals; Cognition Disorders; Cognitive Dysfunction; Dynorphins; Methamphetamine; Mice; Narcotic Antagonists; Receptors, Opioid, kappa | 2023 |
Proteomic Analysis Reveals the Neurotoxic Effects of Chronic Methamphetamine Self-Administration-Induced Cognitive Impairments and the Role of Melatonin-Enhanced Restorative Process during Methamphetamine Withdrawal.
Topics: Animals; Cognitive Dysfunction; Humans; Melatonin; Methamphetamine; Mice; Proteomics; Substance Withdrawal Syndrome | 2023 |
Methamphetamine-Induced Cognitive Deficits and Psychiatric Symptoms Are Associated with Serum Markers of Liver Damage.
Topics: Adolescent; Adult; Alanine Transaminase; Apolipoproteins B; Aspartate Aminotransferases; Biomarkers; Blood Glucose; Case-Control Studies; Chemical and Drug Induced Liver Injury; Cholesterol; Cognitive Dysfunction; Humans; Male; Methamphetamine; Middle Aged; Psychiatric Status Rating Scales; Serum Albumin; Serum Globulins; Substance-Related Disorders; Triglycerides; Young Adult | 2020 |
Cognitive deficits in methamphetamine addiction: Independent contributions of dependence and intelligence.
Topics: Adult; Amphetamine-Related Disorders; Cognitive Dysfunction; Cross-Sectional Studies; Female; Humans; Impulsive Behavior; Intelligence; Male; Memory, Short-Term; Methamphetamine; Neuropsychological Tests | 2020 |
Lifetime Methamphetamine Use Disorder and Reported Sleep Quality in Adults Living with HIV.
Topics: Adult; Amphetamine-Related Disorders; Anti-HIV Agents; Cognitive Dysfunction; Female; HIV Infections; HIV Seronegativity; Humans; Male; Methamphetamine; Middle Aged; Neuropsychological Tests; Self Report; Sleep; Sleep Wake Disorders | 2020 |
Cognitive impairment in methamphetamine users with recent psychosis: A cross-sectional study in Thailand.
Topics: Adult; Amphetamine-Related Disorders; Cognitive Dysfunction; Cross-Sectional Studies; Female; Humans; Male; Methamphetamine; Middle Aged; Neuropsychological Tests; Psychiatric Status Rating Scales; Psychotic Disorders; Surveys and Questionnaires; Thailand | 2020 |
Extended access self-administration of methamphetamine is associated with age- and sex-dependent differences in drug taking behavior and recognition memory in rats.
Topics: Age Factors; Animals; Behavior, Animal; Central Nervous System Stimulants; Cognitive Dysfunction; Disease Models, Animal; Female; Male; Methamphetamine; Nucleus Accumbens; Prefrontal Cortex; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D1; Receptors, N-Methyl-D-Aspartate; Recognition, Psychology; Sex Factors; Substance-Related Disorders | 2020 |
Melatonin ameliorates methamphetamine-induced cognitive impairments by inhibiting neuroinflammation via suppression of the TLR4/MyD88/NFκB signaling pathway in the mouse hippocampus.
Topics: Animals; Anti-Inflammatory Agents; Central Nervous System Stimulants; Cognitive Dysfunction; Hippocampus; Inflammation; Melatonin; Methamphetamine; Mice; Myeloid Differentiation Factor 88; NF-kappa B; Signal Transduction; Toll-Like Receptor 4 | 2021 |
TCA cycle metabolic compromise due to an aberrant S-nitrosoproteome in HIV-associated neurocognitive disorder with methamphetamine use.
Topics: Autopsy; Biological Specimen Banks; Brain; Citric Acid Cycle; Cognitive Dysfunction; Cysteine; HIV Infections; HIV-1; Humans; Male; Methamphetamine; Middle Aged; Mitochondria; Neurons; Nitric Oxide; Protein Processing, Post-Translational; S-Nitrosothiols; Substance-Related Disorders; Synapses | 2021 |
Melatonin protects against methamphetamine-induced Alzheimer's disease-like pathological changes in rat hippocampus.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Antioxidants; Central Nervous System Stimulants; Cognitive Dysfunction; Hippocampus; Learning Disabilities; Male; Maze Learning; Melatonin; Memory Disorders; Methamphetamine; Neuroprotective Agents; Rats; Rats, Wistar | 2021 |
Cognitive improvement among abstinent methamphetamine users: A 2-year prospective longitudinal study.
Topics: Cognition; Cognitive Dysfunction; Humans; Longitudinal Studies; Methamphetamine; Prospective Studies | 2021 |
Effects of HIV-1 Tat and Methamphetamine on Blood-Brain Barrier Integrity and Function
Topics: Atazanavir Sulfate; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biological Transport; Blood-Brain Barrier; Cell Line; Cognitive Dysfunction; HIV Infections; HIV Protease Inhibitors; HIV-1; Humans; Methamphetamine; Multidrug Resistance-Associated Proteins; Rhodamines; tat Gene Products, Human Immunodeficiency Virus; Transendothelial and Transepithelial Migration; Zonula Occludens-1 Protein | 2017 |
Cognitive outcomes in prenatal methamphetamine exposed children aged six to seven years.
Topics: Case-Control Studies; Child; Cognitive Dysfunction; Female; Humans; Male; Methamphetamine; Neuropsychological Tests; Pregnancy; Prenatal Exposure Delayed Effects | 2018 |
Maternal methamphetamine exposure causes cognitive impairment and alteration of neurodevelopment-related genes in adult offspring mice.
Topics: Animals; Cognitive Dysfunction; Female; Gene Expression Regulation, Developmental; Hippocampus; Male; Maze Learning; Memory, Long-Term; Memory, Short-Term; Methamphetamine; Mice; Nucleus Accumbens; Pregnancy; Prenatal Exposure Delayed Effects; Recognition, Psychology; Sex Characteristics | 2018 |
Sustained attention but not effort-based decision-making predicts treatment motivation change in people with methamphetamine dependence.
Topics: Adult; Amphetamine-Related Disorders; Attention; Cognitive Dysfunction; Cohort Studies; Decision Making; Female; Follow-Up Studies; Humans; Longitudinal Studies; Male; Methamphetamine; Motivation; Regression Analysis; Reward; Young Adult | 2018 |
LiCl Pretreatment Ameliorates Adolescent Methamphetamine Exposure-Induced Long-Term Alterations in Behavior and Hippocampal Ultrastructure in Adulthood in Mice.
Topics: Age Factors; Animals; Behavior, Animal; Central Nervous System Stimulants; Cognitive Dysfunction; Enzyme Inhibitors; Glycogen Synthase Kinase 3 beta; Hippocampus; Lithium Chloride; Memory, Short-Term; Methamphetamine; Mice; Prefrontal Cortex | 2019 |
Protective role of metformin against methamphetamine induced anxiety, depression, cognition impairment and neurodegeneration in rat: The role of CREB/BDNF and Akt/GSK3 signaling pathways.
Topics: Animals; Anxiety; Brain-Derived Neurotrophic Factor; Central Nervous System Stimulants; Cognitive Dysfunction; Cyclic AMP Response Element-Binding Protein; Depression; Glycogen Synthase Kinase 3; Hypoglycemic Agents; Male; Metformin; Methamphetamine; Neuroprotective Agents; Proto-Oncogene Proteins c-akt; Rats; Signal Transduction | 2019 |
MMP-9-BDNF pathway is implicated in cognitive impairment of male individuals with methamphetamine addiction during early withdrawal.
Topics: Adult; Amphetamine-Related Disorders; Behavior, Addictive; Brain-Derived Neurotrophic Factor; Cognitive Dysfunction; Drug Users; Humans; Male; Matrix Metalloproteinase 9; Methamphetamine; Middle Aged; Substance Withdrawal Syndrome; Substance-Related Disorders | 2019 |
Methamphetamine-associated cognitive decline is attenuated by neutralizing IL-1 signaling.
Topics: Animals; Central Nervous System Stimulants; Cognitive Dysfunction; Hippocampus; Interleukin-1beta; Locomotion; Male; Methamphetamine; Mice, Inbred C57BL; Neural Stem Cells; Neurons; Signal Transduction; Spatial Learning; Spatial Memory | 2019 |
Conditional Effects of Lifetime Alcohol Consumption on Methamphetamine-Associated Neurocognitive Performance.
Topics: Adult; Alcohol Drinking; Amphetamine-Related Disorders; Central Nervous System Depressants; Central Nervous System Stimulants; Cognitive Dysfunction; Ethanol; Female; Humans; Male; Methamphetamine; Middle Aged; Neuropsychological Tests | 2019 |
The cognitive impairments and psychological wellbeing of methamphetamine dependent patients compared with health controls.
Topics: Adult; Amphetamine-Related Disorders; Analysis of Variance; Central Nervous System Stimulants; Cognitive Dysfunction; Female; Follow-Up Studies; Humans; Longitudinal Studies; Male; Methamphetamine; Neuropsychological Tests; Psychiatric Status Rating Scales | 2016 |
Cumulative and booster effects of tdcs sessions on drug cravings, lapse, and cognitive impairment in methamphetamine use disorder: A case study report.
Topics: Amphetamine-Related Disorders; Cognitive Dysfunction; Craving; Humans; Male; Methamphetamine; Prefrontal Cortex; Recurrence; Stress, Psychological; Transcranial Direct Current Stimulation; Young Adult | 2016 |
Metabolic alterations in the anterior cingulate cortex and related cognitive deficits in late adolescent methamphetamine users.
Topics: Adolescent; Amphetamine-Related Disorders; Aspartic Acid; Brain; Case-Control Studies; Cognitive Dysfunction; Female; Gyrus Cinguli; Humans; Magnetic Resonance Imaging; Male; Methamphetamine; Proton Magnetic Resonance Spectroscopy; Stroop Test; Young Adult | 2018 |
Pattern and related factors of cognitive impairment among chronic methamphetamine users.
Topics: Adult; Central Nervous System Stimulants; China; Cognitive Dysfunction; Educational Status; Female; Humans; Intelligence Tests; Logistic Models; Male; Methamphetamine; Odds Ratio; Prevalence; Risk Factors; Substance-Related Disorders; Surveys and Questionnaires | 2017 |